SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/14/22 Skinvisible, Inc. 10-Q 9/30/22 46:2.5M Edgar Einsteins, Inc./FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 519K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 18K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 18K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K 10: R1 Cover HTML 63K 11: R2 Condensed Consolidated Balance Sheets HTML 107K 12: R3 Condensed Consolidated Balance Sheets HTML 28K (Parenthetical) 13: R4 Condensed Consolidated Statements of Operations HTML 91K (Unuadited) 14: R5 Consolidated Statements of Stockholders' Deficit HTML 50K (Unaudited) 15: R6 Condensed Consolidated Statements of Cash Flows HTML 96K (Unaudited) 16: R7 1. Description of Business and History HTML 20K 17: R8 2. Basis of Presentation and Going Concern HTML 22K 18: R9 3. Summary of Significant Policies HTML 35K 19: R10 4. Intangible and Other Assets HTML 19K 20: R11 5. Related Party Transactions HTML 30K 21: R12 6. Notes Payable HTML 43K 22: R13 8. Stock Options and Warrants HTML 29K 23: R14 9. Commitments and Contingencies HTML 23K 24: R15 10. Stockholders? Deficit HTML 23K 25: R16 11. Subsequent Events HTML 17K 26: R17 2. Basis of Presentation and Going Concern HTML 23K (Policies) 27: R18 3. Summary of Significant Policies (Policies) HTML 58K 28: R19 5. Related Party Transactions (Tables) HTML 26K 29: R20 6. Notes Payable (Tables) HTML 35K 30: R21 8. Stock Options and Warrants (Tables) HTML 27K 31: R22 1. Description of Business and History (Details HTML 16K Narrative) 32: R23 2. Basis of Presentation and Going Concern HTML 27K (Details Narrative) 33: R24 3. Summary of Significant Policies (Details HTML 25K Narrative) 34: R25 4. Intangible and Other Assets (Details Narrative) HTML 22K 35: R26 5. RELATED PARTY TRANSACTIONS - Schedule of HTML 58K Convertible Notes Payable Related Party (Details) 36: R27 5. Related Party Transactions (Details Narrative) HTML 24K 37: R28 7. CONVERTIBLE NOTES PAYABLE - Schedule of HTML 81K Convertible Notes Payable (Details) 38: R29 6. Notes Payable (Details Narrative) HTML 26K 39: R30 8. STOCK OPTIONS AND WARRANTS - Schedule of Option HTML 45K Summary (Details) 40: R31 9. Commitments and Contingencies (Details HTML 23K Narrative) 41: R32 10. Stockholders? Deficit (Details Narrative) HTML 23K 44: XML IDEA XML File -- Filing Summary XML 79K 42: XML XBRL Instance -- skvi10q_htm XML 460K 43: EXCEL IDEA Workbook of Financial Reports XLSX 65K 6: EX-101.CAL XBRL Calculations -- skvi-20220930_cal XML 98K 7: EX-101.DEF XBRL Definitions -- skvi-20220930_def XML 163K 8: EX-101.LAB XBRL Labels -- skvi-20220930_lab XML 434K 9: EX-101.PRE XBRL Presentations -- skvi-20220930_pre XML 357K 5: EX-101.SCH XBRL Schema -- skvi-20220930 XSD 72K 45: JSON XBRL Instance as JSON Data -- MetaLinks 195± 278K 46: ZIP XBRL Zipped Folder -- 0001663577-22-000653-xbrl Zip 134K
CERTIFICATIONS |
I, Terry Howlett, certify that;
1. | I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 of Skinvisible, Inc. (the “registrant”); |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: November 14, 2022
/s/ Terry Howlett
By: Terry Howlett
Title: Chief Executive Officer
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 11/14/22 | None on these Dates | ||
For Period end: | 9/30/22 | |||
List all Filings |